Ghent University Academic Bibliography

Journal Article
A1
open access

A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH

Lucas E Matthyssens (UGent) , Jed G. Nuchtern, Cees P. Van De Ven, Hany O. S. Gabra, Kristin Bjornland, Sabine Irtan, Jakob Stenman, Luca Pio, Kate M. Cross, Stefano Avanzini, et al.

(2022) ANNALS OF SURGERY. 275(3). p.E575-E585

Add to list

Journal Article
A1
open access

A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Laura D. Gamble, Stefania Purgato, Michelle J. Henderson, Simone Di Giacomo, Amanda J. Russell, Paolo Pigini, Jayne Murray, Emanuele Valli, Giorgio Milazzo, Federico M. Giorgi, et al.

(2021) CANCERS. 13(8).

Add to list

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan Molenaar, Matthias Fischer, Johannes Schulte, Angelika Eggert, Gudrun Schleiermacher, Franki Speleman (UGent) , Louis Chesler, et al.

(2020) EUROPEAN JOURNAL OF CANCER. 136. p.52-68

Add to list

The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

Laura Gamble, Stefania Purgato, Simone Di Giacomo, Amanda Russell, Paolo Pigini, Emanuele Valli, Lesley Ashton, Tom Van Maerken (UGent) , Jo Vandesompele (UGent) , Rogier Versteeg, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.

Add to list

A mechanistic classification of clinical phenotypes in neuroblastoma.

Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke, et al.

(2018) SCIENCE. 362(6419). p.1165-1170

Add to list

Journal Article
A1
open access

Targeting tachykinin receptors in neuroblastoma

Anton G Henssen, Andrea Odersky, Annabell Szymansky, Marleen Seiler, Kristina Althoff, Anneleen Beckers (UGent) , Franki Speleman (UGent) , Simon Schäfers, Katleen De Preter (UGent) , Kathy Astrahanseff, et al.

(2017) ONCOTARGET. 8(1). p.430-443

Add to list

Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Lucas Moreno, Hubert Caron, Birgit Geoerger, Angelika Eggert, Gudrun Schleiermacher, Penelope Brock, Dominique Valteau-Couanet, Louis Chesler, Johannes Schulte, Katleen De Preter (UGent) , et al.

(2017) EXPERT OPINION ON DRUG DISCOVERY. 12(8). p.801-811

Add to list

Targeting MYCN-driven transcription by BET-bromodomain inhibition

Anton G Henssen, Kristina Althoff, Andrea Odersky, Anneleen Beckers (UGent) , Richard Koche, Franki Speleman (UGent) , Simon Schaefer, Emma Bell, Maike Nortmeyer, Frank Westermann, et al.

(2016) CLINICAL CANCER RESEARCH. 22(10). p.2470-2481

Add to list

Journal Article
A1
open access

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Johannes Fabian, Desirée Opitz, Kristina Althoff, Marco Lodrini, Barbara Hero, Ruth Volland, Anneleen Beckers (UGent) , Katleen De Preter (UGent) , Anneleen Decock (UGent) , Nitin Patil, et al.

(2016) ONCOTARGET. 7(41). p.66344-66359

Add to list

Journal Article
A1
open access

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Melanie Schwermer, Sangkyun Lee, Johannes Koester, Tom Van Maerken (UGent) , Harald Stephan, Angelika Eggert, Katharina Morik, Johannes H Schulte and Alexander Schramm

(2015) ONCOTARGET. 6(17). p.15425-15435

Academic Bibliography

A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH

A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

A mechanistic classification of clinical phenotypes in neuroblastoma.

Targeting tachykinin receptors in neuroblastoma

Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Targeting MYCN-driven transcription by BET-bromodomain inhibition

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Contents

Support

Contact